Eli Lilly & Co. vs McKesson Corporation
LLY vs MCK — side-by-side comparison from reported financials. LLY leads 8, MCK leads 3 of 11 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
McKesson Corporation
MCK · Healthcare
$938.84+0.92%Solid
| Metric | LLY | MCK |
|---|---|---|
| Price | $1 177.20 | $938.84 |
| Market cap | $1.05T | $109B |
| Revenue (TTM) | $79.7B | $411B |
| Revenue growth | +31.7% | +13.4% |
| Net margin | 33.5% | 1.1% |
| Free cash flow | $18.2B | $6.42B |
| Net cash (debt) | ($35.2B) | ($4.81B) |
| 1-year price return | +37.6% | +23.9% |
| P/E | 41.6 | 23.8 |
| P/E vs own history (cheap-side %) | 88% | 59% |
| Dividend yield | 0.52% | 0.36% |
| Return on equity | 93% | 39% |
| Altman Z-score | 7.10 | 2.25 |
| CV checks passed | 11 of 11 | 11 of 11 |
| Employees | 50,000 | 43,000 |
Full résumé-style profiles: LLY CV · MCK CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.